Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRallybio Corp Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$1.20 | -$1.20 | -$1.20 |
| Q2 2026 | 1 | -$1.28 | -$1.28 | -$1.28 |
| Q3 2026 | 1 | -$1.44 | -$1.44 | -$1.44 |
| Q4 2026 | 1 | -$1.60 | -$1.60 | -$1.60 |
Rallybio Corp Earnings Date And Information
Rallybio Corp last posted its earnings results on Thursday, March 12th, 2026. The company reported $-1.28 earnings per share for the quarter, missing analysts' consensus estimates of $-1.24 by $0.04. The company had revenue of 222.00 K for the quarter and had revenue of 858.00 K for the year. Rallybio Corp has generated $-2 earnings per share over the last year ($-1.59 diluted earnings per share) and currently has a price-to-earnings ratio of -8.52. Rallybio Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Rallybio Corp Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/16/2026 | Q4 2025 | N/A | -$1.11 | N/A | $100.00 K | $222.00 K |
| 11/06/2025 | Q3 2025 | -$0.25 | $2.84 | 3.09 | $66.67 K | $212.00 K |
| 08/07/2025 | Q2 2025 | -$0.20 | -$1.76 | -1.57 | $13.33 K | $212.00 K |
| 05/08/2025 | Q1 2025 | -$0.21 | -$1.68 | -1.47 | $13.33 K | $212.00 K |
| 03/13/2025 | Q4 2024 | -$0.27 | -$2.00 | -1.73 | $149.50 K | $38.00 K |
| 11/07/2024 | Q3 2024 | -$0.36 | -$2.08 | -1.72 | $75.00 K | $299.00 K |
| 08/08/2024 | Q2 2024 | -$0.42 | -$2.96 | -2.54 | $166.67 K | $299.00 K |
| 05/09/2024 | Q1 2024 | -$0.50 | -$3.76 | -3.26 | N/A | $0 |
| 03/12/2024 | Q4 2023 | -$0.44 | -$4.00 | -3.56 | N/A | $228.00 K |
| 11/09/2023 | Q3 2023 | -$0.51 | -$3.60 | -3.09 | N/A | $0 |
| 08/08/2023 | Q2 2023 | -$0.48 | -$3.68 | -3.2 | N/A | $0 |
| 05/09/2023 | Q1 2023 | -$0.50 | -$3.44 | -2.94 | N/A | $0 |
| 03/06/2023 | Q4 2022 | -$0.63 | -$3.68 | -3.05 | N/A | $0 |
| 11/07/2022 | Q3 2022 | -$0.54 | -$4.80 | -4.26 | N/A | $0 |
| 08/08/2022 | Q2 2022 | -$0.61 | -$4.56 | -3.95 | N/A | $0 |
| 05/10/2022 | Q1 2022 | -$0.48 | -$3.84 | -3.36 | N/A | $0 |
| 03/15/2022 | Q4 2021 | -$0.39 | -$3.36 | -2.97 | N/A | $0 |
| 11/10/2021 | Q3 2021 | -$0.89 | -$2.96 | -2.07 | N/A | $0 |
| 09/09/2021 | Q2 2021 | -$2.80 | -$2.88 | -0.08 | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$4.80 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rallybio Corp Earnings: FAQ's
The conference call for Rallybio Corp's latest earnings report can be listened to online.
The conference call transcript for Rallybio Corp's latest earnings report can be read online.
Rallybio Corp (:RLYB) has a recorded annual revenue of $858.00 K.
Rallybio Corp (:RLYB) has a recorded net income of $-8,978,000.Rallybio Corp has generated $-1.59 earnings per share over the last four quarters.
Rallybio Corp (:RLYB) has a price-to-earnings ratio of -8.52 and price/earnings-to-growth ratio is -0.04.